12 Health Care Stocks Moving In Thursday's Pre-Market Session
I'm LongbridgeAI, I can summarize articles.In Thursday's pre-market session, several healthcare stocks saw significant movement. Aditxt surged 247.7% to $0.02, while CervoMed rose 25.72% to $4.79. Other gainers included QTREX Quantum, Butterfly Network, Spero Therapeutics, and Agape ATP. Conversely, Profusa dropped 31.0% to $0.18, NewGenIvf fell 22.33% to $0.62, and Elicio Therapeutics declined 20.73% to $3.73. Losers also included Ernexa Therapeutics, NovoCure, and Lunai Bioworks.
Gainers
- Aditxt (NASDAQ:ADTX) stock moved upwards by 247.7% to $0.02 during Thursday's pre-market session.
- CervoMed (NASDAQ:CRVO) shares increased by 25.72% to $4.79. The market value of their outstanding shares is at $35.2 million.
- QTREX Quantum (NASDAQ:QTEX) stock rose 22.63% to $2.33. The market value of their outstanding shares is at $99.9 million.
- Butterfly Network (NYSE:BFLY) stock increased by 16.85% to $6.67. The market value of their outstanding shares is at $1.4 billion.
- Spero Therapeutics (NASDAQ:SPRO) shares rose 16.11% to $2.45. The market value of their outstanding shares is at $122.1 million.
- Agape ATP (NASDAQ:ATPC) shares rose 15.75% to $3.16. The market value of their outstanding shares is at $2.7 million.
Losers
- Profusa (NASDAQ:PFSA) shares declined by 31.0% to $0.18 during Thursday's pre-market session. The company's market cap stands at $1.1 million.
- NewGenIvf Group (NASDAQ:NIVF) stock decreased by 22.33% to $0.62. The market value of their outstanding shares is at $2.2 million.
- Elicio Therapeutics (NASDAQ:ELTX) shares fell 20.73% to $3.73. The market value of their outstanding shares is at $89.8 million.
- Ernexa Therapeutics (NASDAQ:ERNA) shares declined by 14.95% to $5.01. The market value of their outstanding shares is at $6.8 million.
- NovoCure (NASDAQ:NVCR) stock fell 14.57% to $15.25. The company's market cap stands at $2.0 billion.
- Lunai Bioworks (NASDAQ:LNAI) stock fell 14.1% to $3.44. The market value of their outstanding shares is at $18.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
